Results per Page:
From Data to Diagnosis: GREGoR aims to demystify rare diseases
From the Genomics Research to Elucidate the Genetics of Rare Diseases (GREGoR) Consortium, including the Fred Hutch/University of Washington/Seattle Children’s Cancer Consortium
Looking beyond suspect genes in cancer
Fred Hutch is among 10 institutions in the U.S., the U.K. and Europe collaborating to find the function of every protein-coding gene in the human genome
Biomarkers, tumor markers and tumor boards: What cancer patients need to know
Cancer care is changing — as are the clinical tools, tests and the terms used to diagnose and predict its path and treatment
Search for the genetic basis of dyslexia
From Drs. Wendy Raskind, Ellen Wijsman, and colleagues, University of Washington.
Virologist and HIV expert Dr. Michael Emerman retires
Emerman considers mentorship his most important duty in science
Fred Hutch study finds genetic driver of drug resistance in small cell lung cancer
Researchers use CRISPR-Cas9 gene-editing tool on tumor cells grown in mice to better model how tumors that initially respond to chemotherapy become resistant
Managing mountains of genomic data
Tools invented at Fred Hutch are helping researchers analyze the enormous global database of genomic sequences of the virus that causes COVID-19 to better understand how pathogens evolve and spread
50 years of doing hard things
Founded in 1975 to honor a brother, Fred Hutch Cancer Center pursued bold science, pioneered a cure for blood diseases that changed medicine and became a world-class biomedical research and clinical care institution
More to brain tumors than meets the eye
Fred Hutch researchers find new way to classify tumors based on their underlying biology rather than how they look
Science Says: The promise of precision medicine
How understanding unique traits of individuals and their cancers can lead to precise treatments
Team of top researchers prepares for endemic COVID-19
$15M Howard Hughes Medical Institute grant shared by 8 scientists at Fred Hutch and UW
Researchers link mutations in coronavirus' internal machinery to higher risk of severe disease
Early COVID-19 patients were more likely to be hospitalized if virus carried genetic trait
Toward better cures for kids with AML: Q&A with Dr. Soheil Meshinchi
How researchers are developing personalized therapies for the deadliest childhood leukemia that have fewer side effects
Fred Hutch scientist Dr. Trevor Bedford receives MacArthur Fellowship
Recognized for research and public health contributions in tracking viral spread and evolution
Deleted SARS-CoV-2 sequences from early in Wuhan outbreak offer clues
Detective work by Hutch evolutionary biologist reconstructs and analyzes data to provide evidence on pandemic origins
Prostate cancer researcher Dr. Janet Stanford retires after three decades
Career of discoveries about prostate cancer genetics, risks, outcomes
Democratizing DNA-based health risk scores
Hutch-led consortium receives $9.8M grant to improve genetic risk prediction for cardiovascular disease in racially and ethnically diverse populations
Can a tumor that acts like a microbe help us develop better cancer therapies?
Understanding the genetics underlying spontaneous regression of an infectious tumor in Tasmanian devils could point us toward new treatment targets
Dr. Hans-Peter Kiem elected vice president of American Society of Gene & Cell Therapy
After serving 1 year as vice president, Kiem will serve as president-elect and president of the society